Report Cover

Global Equine Pharmaceuticals and Supplements Market Growth 2020-2025


According to this study, over the next five years the Equine Pharmaceuticals and Supplements market will register a 4.7%% CAGR in terms of revenue, the global market size will reach $ 1314.6 million by 2025, from $ 1095.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Equine Pharmaceuticals and Supplements business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Equine Pharmaceuticals and Supplements market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Equine Pharmaceuticals and Supplements, covering the supply chain analysis, impact assessment to the Equine Pharmaceuticals and Supplements market size growth rate in several scenarios, and the measures to be undertaken by Equine Pharmaceuticals and Supplements companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
    Pharmaceuticals
    Supplements

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
    Thoroughbred Horse
    Other Types of Horses

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
    Boehringer Ingelheim
    Kyoritsu Seiyaku
    Merck Animal Health
    Bayer Animal Health
    Elanco Animal Health
    Zoetis
    Virbac
    Dechra Veterinary Products
    Norbrook Equine
    CEVA
    Vetoquinol
    Ouro Fino Saude
    Audevard
    Protexin Healthcare

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
    To study and analyze the global Equine Pharmaceuticals and Supplements consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
    To understand the structure of Equine Pharmaceuticals and Supplements market by identifying its various subsegments.
    Focuses on the key global Equine Pharmaceuticals and Supplements manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Equine Pharmaceuticals and Supplements with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Equine Pharmaceuticals and Supplements submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions (FAQ) :

The applications of Equine Pharmaceuticals and Supplements Market are: Thoroughbred Horse and Other Types of Horses
Contenders forming a competition in Equine Pharmaceuticals and Supplements market are: Boehringer Ingelheim, Kyoritsu Seiyaku, Merck Animal Health, Bayer Animal Health, Elanco Animal Health, Zoetis, Virbac, Dechra Veterinary Products, Norbrook Equine, CEVA, Vetoquinol, Ouro Fino Saude, Audevard and Protexin Healthcare
The Product type classification of Equine Pharmaceuticals and Supplements Market is consisting of: Pharmaceuticals and Supplements

1 Scope of the Report
    1.1 Market Introduction
    1.2 Research Objectives
    1.3 Years Considered
    1.4 Market Research Methodology
    1.5 Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Equine Pharmaceuticals and Supplements Consumption 2015-2025
        2.1.2 Equine Pharmaceuticals and Supplements Consumption CAGR by Region
    2.2 Equine Pharmaceuticals and Supplements Segment by Type
        2.2.1 Pharmaceuticals
        2.2.2 Supplements
    2.3 Equine Pharmaceuticals and Supplements Consumption by Type
        2.3.1 Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
        2.3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2015-2020)
        2.3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2015-2020)
    2.4 Equine Pharmaceuticals and Supplements Segment by Application
        2.4.1 Thoroughbred Horse
        2.4.2 Other Types of Horses
    2.5 Equine Pharmaceuticals and Supplements Consumption by Application
        2.5.1 Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
        2.5.2 Global Equine Pharmaceuticals and Supplements Value and Market Share by Type (2015-2020)
        2.5.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2015-2020)

3 Global Equine Pharmaceuticals and Supplements by Company
    3.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company
        3.1.1 Global Equine Pharmaceuticals and Supplements Sales by Company (2018-2020)
        3.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2018-2020)
    3.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company
        3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Company (2018-2020)
        3.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2018-2020)
    3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Company
    3.4 Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution, Sales Area, Type by Company
        3.4.1 Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution and Sales Area by Company
        3.4.2 Players Equine Pharmaceuticals and Supplements Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 Equine Pharmaceuticals and Supplements by Regions
    4.1 Equine Pharmaceuticals and Supplements by Regions
    4.2 Americas Equine Pharmaceuticals and Supplements Consumption Growth
    4.3 APAC Equine Pharmaceuticals and Supplements Consumption Growth
    4.4 Europe Equine Pharmaceuticals and Supplements Consumption Growth
    4.5 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Growth

5 Americas
    5.1 Americas Equine Pharmaceuticals and Supplements Consumption by Countries
        5.1.1 Americas Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020)
        5.1.2 Americas Equine Pharmaceuticals and Supplements Value by Countries (2015-2020)
    5.2 Americas Equine Pharmaceuticals and Supplements Consumption by Type
    5.3 Americas Equine Pharmaceuticals and Supplements Consumption by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
    5.8 Key Economic Indicators of Few Americas Countries

6 APAC
    6.1 APAC Equine Pharmaceuticals and Supplements Consumption by Regions
        6.1.1 APAC Equine Pharmaceuticals and Supplements Consumption by Regions (2015-2020)
        6.1.2 APAC Equine Pharmaceuticals and Supplements Value by Regions (2015-2020)
    6.2 APAC Equine Pharmaceuticals and Supplements Consumption by Type
    6.3 APAC Equine Pharmaceuticals and Supplements Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
    7.1 Europe Equine Pharmaceuticals and Supplements by Countries
        7.1.1 Europe Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020)
        7.1.2 Europe Equine Pharmaceuticals and Supplements Value by Countries (2015-2020)
    7.2 Europe Equine Pharmaceuticals and Supplements Consumption by Type
    7.3 Europe Equine Pharmaceuticals and Supplements Consumption by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
    7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
    8.1 Middle East & Africa Equine Pharmaceuticals and Supplements by Countries
        8.1.1 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020)
        8.1.2 Middle East & Africa Equine Pharmaceuticals and Supplements Value by Countries (2015-2020)
    8.2 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Type
    8.3 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Marketing, Distributors and Customer
    10.1 Sales Channel
        10.1.1 Direct Channels
        10.1.2 Indirect Channels
    10.2 Equine Pharmaceuticals and Supplements Distributors
    10.3 Equine Pharmaceuticals and Supplements Customer

11 Global Equine Pharmaceuticals and Supplements Market Forecast
    11.1 Global Equine Pharmaceuticals and Supplements Consumption Forecast (2021-2025)
    11.2 Global Equine Pharmaceuticals and Supplements Forecast by Regions
        11.2.1 Global Equine Pharmaceuticals and Supplements Forecast by Regions (2021-2025)
        11.2.2 Global Equine Pharmaceuticals and Supplements Value Forecast by Regions (2021-2025)
        11.2.3 Americas Consumption Forecast
        11.2.4 APAC Consumption Forecast
        11.2.5 Europe Consumption Forecast
        11.2.6 Middle East & Africa Consumption Forecast
    11.3 Americas Forecast by Countries
        11.3.1 United States Market Forecast
        11.3.2 Canada Market Forecast
        11.3.3 Mexico Market Forecast
        11.3.4 Brazil Market Forecast
   11.4 APAC Forecast by Countries
        11.4.1 China Market Forecast
        11.4.2 Japan Market Forecast
        11.4.3 Korea Market Forecast
        11.4.4 Southeast Asia Market Forecast
        11.4.5 India Market Forecast
        11.4.6 Australia Market Forecast
    11.5 Europe Forecast by Countries
        11.5.1 Germany Market Forecast
        11.5.2 France Market Forecast
        11.5.3 UK Market Forecast
        11.5.4 Italy Market Forecast
        11.5.5 Russia Market Forecast
    11.6 Middle East & Africa Forecast by Countries
        11.6.1 Egypt Market Forecast
        11.6.2 South Africa Market Forecast
        11.6.3 Israel Market Forecast
        11.6.4 Turkey Market Forecast
        11.6.5 GCC Countries Market Forecast
    11.7 Global Equine Pharmaceuticals and Supplements Forecast by Type
    11.8 Global Equine Pharmaceuticals and Supplements Forecast by Application

12 Key Players Analysis
    12.1 Boehringer Ingelheim
        12.1.1 Company Information
        12.1.2 Equine Pharmaceuticals and Supplements Product Offered
        12.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.1.4 Main Business Overview
        12.1.5 Boehringer Ingelheim Latest Developments
    12.2 Kyoritsu Seiyaku
        12.2.1 Company Information
        12.2.2 Equine Pharmaceuticals and Supplements Product Offered
        12.2.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.2.4 Main Business Overview
        12.2.5 Kyoritsu Seiyaku Latest Developments
    12.3 Merck Animal Health
        12.3.1 Company Information
        12.3.2 Equine Pharmaceuticals and Supplements Product Offered
        12.3.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.3.4 Main Business Overview
        12.3.5 Merck Animal Health Latest Developments
    12.4 Bayer Animal Health
        12.4.1 Company Information
        12.4.2 Equine Pharmaceuticals and Supplements Product Offered
        12.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.4.4 Main Business Overview
        12.4.5 Bayer Animal Health Latest Developments
    12.5 Elanco Animal Health
        12.5.1 Company Information
        12.5.2 Equine Pharmaceuticals and Supplements Product Offered
        12.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.5.4 Main Business Overview
        12.5.5 Elanco Animal Health Latest Developments
    12.6 Zoetis
        12.6.1 Company Information
        12.6.2 Equine Pharmaceuticals and Supplements Product Offered
        12.6.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.6.4 Main Business Overview
        12.6.5 Zoetis Latest Developments
    12.7 Virbac
        12.7.1 Company Information
        12.7.2 Equine Pharmaceuticals and Supplements Product Offered
        12.7.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.7.4 Main Business Overview
        12.7.5 Virbac Latest Developments
    12.8 Dechra Veterinary Products
        12.8.1 Company Information
        12.8.2 Equine Pharmaceuticals and Supplements Product Offered
        12.8.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.8.4 Main Business Overview
        12.8.5 Dechra Veterinary Products Latest Developments
    12.9 Norbrook Equine
        12.9.1 Company Information
        12.9.2 Equine Pharmaceuticals and Supplements Product Offered
        12.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.9.4 Main Business Overview
        12.9.5 Norbrook Equine Latest Developments
    12.10 CEVA
        12.10.1 Company Information
        12.10.2 Equine Pharmaceuticals and Supplements Product Offered
        12.10.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.10.4 Main Business Overview
        12.10.5 CEVA Latest Developments
    12.11 Vetoquinol
        12.11.1 Company Information
        12.11.2 Equine Pharmaceuticals and Supplements Product Offered
        12.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.11.4 Main Business Overview
        12.11.5 Vetoquinol Latest Developments
    12.12 Ouro Fino Saude
        12.12.1 Company Information
        12.12.2 Equine Pharmaceuticals and Supplements Product Offered
        12.12.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.12.4 Main Business Overview
        12.12.5 Ouro Fino Saude Latest Developments
    12.13 Audevard
        12.13.1 Company Information
        12.13.2 Equine Pharmaceuticals and Supplements Product Offered
        12.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.13.4 Main Business Overview
        12.13.5 Audevard Latest Developments
    12.14 Protexin Healthcare
        12.14.1 Company Information
        12.14.2 Equine Pharmaceuticals and Supplements Product Offered
        12.14.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
        12.14.4 Main Business Overview
        12.14.5 Protexin Healthcare Latest Developments

13 Research Findings and Conclusion

List of Tables Table 1. Research Methodology Table 2. Data Source Table 3. Equine Pharmaceuticals and Supplements Consumption CAGR by Region 2015-2025 ($ Millions) Table 4. Major Players of Pharmaceuticals Table 5. Major Players of Supplements Table 6. Global Consumption Sales by Type (2015-2020) Table 7. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020) Table 8. Global Equine Pharmaceuticals and Supplements Revenue by Type (2015-2020) ($ million) Table 9. Global Equine Pharmaceuticals and Supplements Value Market Share by Type (2015-2020) ($ Millions) Table 10. Global Equine Pharmaceuticals and Supplements Sale Price by Type (2015-2020) Table 11. Global Consumption Sales by Application (2015-2020) Table 12. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020) Table 13. Global Equine Pharmaceuticals and Supplements Value by Application (2015-2020) Table 14. Global Equine Pharmaceuticals and Supplements Value Market Share by Application (2015-2020) Table 15. Global Equine Pharmaceuticals and Supplements Sale Price by Application (2015-2020) Table 16. Global Equine Pharmaceuticals and Supplements Sales by Company (2017-2019) (K Units) Table 17. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2017-2019) Table 18. Global Equine Pharmaceuticals and Supplements Revenue by Company (2017-2019) ($ Millions) Table 19. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2017-2019) Table 20. Global Equine Pharmaceuticals and Supplements Sale Price by Company (2017-2019) Table 21. Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution and Sales Area by Manufacturers Table 22. Players Equine Pharmaceuticals and Supplements Products Offered Table 23. Equine Pharmaceuticals and Supplements Concentration Ratio (CR3, CR5 and CR10) (2017-2019) Table 24. Global Equine Pharmaceuticals and Supplements Consumption by Regions 2015-2020 (K Units) Table 25. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Regions 2015-2020 Table 26. Global Equine Pharmaceuticals and Supplements Value by Regions 2015-2020 ($ Millions) Table 27. Global Equine Pharmaceuticals and Supplements Value Market Share by Regions 2015-2020 Table 28. Americas Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020) (K Units) Table 29. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Countries (2015-2020) Table 30. Americas Equine Pharmaceuticals and Supplements Value by Countries (2015-2020) ($ Millions) Table 31. Americas Equine Pharmaceuticals and Supplements Value Market Share by Countries (2015-2020) Table 32. Americas Equine Pharmaceuticals and Supplements Consumption by Type (2015-2020) (K Units) Table 33. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020) Table 34. Americas Equine Pharmaceuticals and Supplements Consumption by Application (2015-2020) (K Units) Table 35. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020) Table 36. APAC Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020) (K Units) Table 37. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Countries (2015-2020) Table 38. APAC Equine Pharmaceuticals and Supplements Value by Regions (2015-2020) ($ Millions) Table 39. APAC Equine Pharmaceuticals and Supplements Value Market Share by Regions (2015-2020) Table 40. APAC Equine Pharmaceuticals and Supplements Consumption by Type (2015-2020) (K Units) Table 41. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020) Table 42. APAC Equine Pharmaceuticals and Supplements Consumption by Application (2015-2020) (K Units) Table 43. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020) Table 44. Europe Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020) (K Units) Table 45. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Countries (2015-2020) Table 46. Europe Equine Pharmaceuticals and Supplements Value by Countries (2015-2020) ($ Millions) Table 47. Europe Equine Pharmaceuticals and Supplements Value Market Share by Countries (2015-2020) Table 48. Europe Equine Pharmaceuticals and Supplements Consumption by Type (2015-2020) (K Units) Table 49. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020) Table 50. Europe Equine Pharmaceuticals and Supplements Consumption by Application (2015-2020) (K Units) Table 51. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020) Table 52. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020) (K Units) Table 53. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Countries (2015-2020) Table 54. Middle East & Africa Equine Pharmaceuticals and Supplements Value by Countries (2015-2020) ($ Millions) Table 55. Middle East & Africa Equine Pharmaceuticals and Supplements Value Market Share by Countries (2015-2020) Table 56. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Type (2015-2020) (K Units) Table 57. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020) Table 58. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Application (2015-2020) (K Units) Table 59. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020) Table 60. Equine Pharmaceuticals and Supplements Distributors List Table 61. Equine Pharmaceuticals and Supplements Customer List Table 62. Global Equine Pharmaceuticals and Supplements Consumption Forecast by Countries (2021-2025) (K Units) Table 63. Global Equine Pharmaceuticals and Supplements Consumption Market Forecast by Regions Table 64. Global Equine Pharmaceuticals and Supplements Value Forecast by Countries (2021-2025) ($ Millions) Table 65. Global Equine Pharmaceuticals and Supplements Value Market Share Forecast by Regions Table 66. Global Equine Pharmaceuticals and Supplements Consumption Forecast by Type (2021-2025) (K Units) Table 67. Global Equine Pharmaceuticals and Supplements Consumption Market Share Forecast by Type (2021-2025) Table 68. Global Equine Pharmaceuticals and Supplements Value Forecast by Type (2021-2025) ($ Millions) Table 69. Global Equine Pharmaceuticals and Supplements Value Market Share Forecast by Type (2021-2025) Table 70. Global Equine Pharmaceuticals and Supplements Consumption Forecast by Application (2021-2025) (K Units) Table 71. Global Equine Pharmaceuticals and Supplements Consumption Market Share Forecast by Application (2021-2025) Table 72. Global Equine Pharmaceuticals and Supplements Value Forecast by Application (2021-2025) ($ Millions) Table 73. Global Equine Pharmaceuticals and Supplements Value Market Share Forecast by Application (2021-2025) Table 74. Boehringer Ingelheim Product Offered Table 75. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 76. Boehringer Ingelheim Main Business Table 77. Boehringer Ingelheim Latest Developments Table 78. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors Table 79. Kyoritsu Seiyaku Product Offered Table 80. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 81. Kyoritsu Seiyaku Main Business Table 82. Kyoritsu Seiyaku Latest Developments Table 83. Kyoritsu Seiyaku Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors Table 84. Merck Animal Health Product Offered Table 85. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 86. Merck Animal Health Main Business Table 87. Merck Animal Health Latest Developments Table 88. Merck Animal Health Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors Table 89. Bayer Animal Health Product Offered Table 90. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 91. Bayer Animal Health Main Business Table 92. Bayer Animal Health Latest Developments Table 93. Bayer Animal Health Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors Table 94. Elanco Animal Health Product Offered Table 95. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 96. Elanco Animal Health Main Business Table 97. Elanco Animal Health Latest Developments Table 98. Elanco Animal Health Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors Table 99. Zoetis Product Offered Table 100. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 101. Zoetis Main Business Table 102. Zoetis Latest Developments Table 103. Zoetis Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors Table 104. Virbac Product Offered Table 105. Virbac Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors Table 106. Virbac Main Business Table 107. Virbac Latest Developments Table 108. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 109. Dechra Veterinary Products Product Offered Table 110. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 111. Dechra Veterinary Products Main Business Table 112. Dechra Veterinary Products Latest Developments Table 113. Dechra Veterinary Products Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors Table 114. Norbrook Equine Product Offered Table 115. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 116. Norbrook Equine Main Business Table 117. Norbrook Equine Latest Developments Table 118. Norbrook Equine Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors Table 119. CEVA Product Offered Table 120. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 121. CEVA Main Business Table 122. CEVA Latest Developments Table 123. CEVA Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors Table 124. Vetoquinol Product Offered Table 125. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 126. Vetoquinol Main Business Table 127. Vetoquinol Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 128. Vetoquinol Latest Developments Table 129. Ouro Fino Saude Product Offered Table 130. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 131. Ouro Fino Saude Main Business Table 132. Ouro Fino Saude Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 133. Ouro Fino Saude Latest Developments Table 134. Audevard Product Offered Table 135. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 136. Audevard Main Business Table 137. Audevard Latest Developments Table 138. Audevard Basic Information, Manufacturing Base, Sales Area and Its Competitors Table 139. Protexin Healthcare Product Offered Table 140. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E) Table 141. Protexin Healthcare Main Business Table 142. Protexin Healthcare Latest Developments Table 143. Protexin Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors List of Figures Figure 1. Picture of Equine Pharmaceuticals and Supplements Figure 2. Equine Pharmaceuticals and Supplements Report Years Considered Figure 3. Market Research Methodology Figure 4. Global Equine Pharmaceuticals and Supplements Consumption Growth Rate 2015-2025 (K Units) Figure 5. Global Equine Pharmaceuticals and Supplements Value Growth Rate 2015-2025 ($ Millions) Figure 6. Product Picture of Pharmaceuticals Figure 7. Product Picture of Supplements Figure 8. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020) Figure 9. Global Equine Pharmaceuticals and Supplements Value Market Share by Type (2015-2020) Figure 10. Equine Pharmaceuticals and Supplements Consumed in Thoroughbred Horse Figure 11. Global Equine Pharmaceuticals and Supplements Market: Thoroughbred Horse (2015-2020) (K Units) Figure 12. Global Equine Pharmaceuticals and Supplements Market: Thoroughbred Horse (2015-2020) ($ Millions) Figure 13. Equine Pharmaceuticals and Supplements Consumed in Other Types of Horses Figure 14. Global Equine Pharmaceuticals and Supplements Market: Other Types of Horses (2015-2020) (K Units) Figure 15. Global Equine Pharmaceuticals and Supplements Market: Other Types of Horses (2015-2020) ($ Millions) Figure 16. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020) Figure 17. Global Equine Pharmaceuticals and Supplements Value Market Share by Application (2015-2020) Figure 18. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2017 Figure 19. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2019 Figure 20. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company in 2017 Figure 21. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company in 2019 Figure 22. Global Equine Pharmaceuticals and Supplements Sale Price by Company in 2019 Figure 23. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Regions 2015-2020 Figure 24. Global Equine Pharmaceuticals and Supplements Value Market Share by Regions 2015-2020 Figure 25. Americas Equine Pharmaceuticals and Supplements Consumption 2015-2020 (K Units) Figure 26. Americas Equine Pharmaceuticals and Supplements Value 2015-2020 ($ Millions) Figure 27. APAC Equine Pharmaceuticals and Supplements Consumption 2015-2020 (K Units) Figure 28. APAC Equine Pharmaceuticals and Supplements Value 2015-2020 ($ Millions) Figure 29. Europe Equine Pharmaceuticals and Supplements Consumption 2015-2020 (K Units) Figure 30. Europe Equine Pharmaceuticals and Supplements Value 2015-2020 ($ Millions) Figure 31. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption 2015-2020 (K Units) Figure 32. Middle East & Africa Equine Pharmaceuticals and Supplements Value 2015-2020 ($ Millions) Figure 33. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Countries in 2019 Figure 34. Americas Equine Pharmaceuticals and Supplements Value Market Share by Countries in 2019 Figure 35. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Type in 2019 Figure 36. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Application in 2019 Figure 37. United States Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 38. United States Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 39. Canada Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 40. Canada Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 41. Mexico Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 42. Mexico Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 43. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Countries in 2019 Figure 44. APAC Equine Pharmaceuticals and Supplements Value Market Share by Regions in 2019 Figure 45. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Type in 2019 Figure 46. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Application in 2019 Figure 47. China Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 48. China Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 49. Japan Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 50. Japan Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 51. Korea Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 52. Korea Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 53. Southeast Asia Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 54. Southeast Asia Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 55. India Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 56. India Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 57. Australia Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 58. Australia Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 59. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Countries in 2019 Figure 60. Europe Equine Pharmaceuticals and Supplements Value Market Share by Countries in 2019 Figure 61. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Type in 2019 Figure 62. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Application in 2019 Figure 63. Germany Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 64. Germany Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 65. France Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 66. France Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 67. UK Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 68. UK Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 69. Italy Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 70. Italy Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 71. Russia Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 72. Russia Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 73. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Countries in 2019 Figure 74. Middle East & Africa Equine Pharmaceuticals and Supplements Value Market Share by Countries in 2019 Figure 75. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Type in 2019 Figure 76. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Application in 2019 Figure 77. Egypt Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 78. Egypt Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 79. South Africa Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 80. South Africa Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 81. Israel Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 82. Israel Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 83. Turkey Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 84. Turkey Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 85. GCC Countries Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units) Figure 86. GCC Countries Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions) Figure 87. Global Equine Pharmaceuticals and Supplements Consumption Growth Rate Forecast (2021-2025) (K Units) Figure 88. Global Equine Pharmaceuticals and Supplements Value Growth Rate Forecast (2021-2025) ($ Millions) Figure 89. Americas Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 90. Americas Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 91. APAC Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 92. APAC Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 93. Europe Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 94. Europe Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 95. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 96. Middle East & Africa Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 97. United States Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 98. United States Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 99. Canada Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 100. Canada Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 101. Mexico Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 102. Mexico Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 103. Brazil Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 104. Brazil Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 105. China Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 106. China Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 107. Japan Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 108. Japan Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 109. Korea Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 110. Korea Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 111. Southeast Asia Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 112. Southeast Asia Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 113. India Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 114. India Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 115. Australia Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 116. Australia Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 117. Germany Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 118. Germany Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 119. France Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 120. France Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 121. UK Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 122. UK Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 123. Italy Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 124. Italy Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 125. Russia Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 126. Russia Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 127. Spain Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 128. Spain Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 129. Egypt Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 130. Egypt Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 131. South Africa Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 132. South Africa Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 133. Israel Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 134. Israel Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 135. Turkey Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 136. Turkey Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 137. GCC Countries Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units) Figure 138. GCC Countries Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions) Figure 139. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 140. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 141. Merck Animal Health Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 142. Bayer Animal Health Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 143. Elanco Animal Health Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 144. Zoetis Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 145. Virbac Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 146. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 147. Norbrook Equine Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 148. CEVA Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 149. Vetoquinol Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 150. Ouro Fino Saude Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 151. Audevard Equine Pharmaceuticals and Supplements Market Share (2018-2020) Figure 152. Protexin Healthcare Equine Pharmaceuticals and Supplements Market Share (2018-2020)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us